[New drug therapy of adult attention deficit hyperactivity disorder--evaluation of efficacy of milnacipran].
Masuko
Hirofumi
H
D018759:Adrenergic Uptake Inhibitors / Q000627:therapeutic use*; D000328:Adult; D020817:Asperger Syndrome / Q000188:drug therapy*; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy*; D003521:Cyclopropanes / Q000627:therapeutic use*; D006801:Humans; D000078764:Milnacipran; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*
D018759:Adrenergic Uptake Inhibitors; D003521:Cyclopropanes; D000078764:Milnacipran; D017367:Selective Serotonin Reuptake Inhibitors